Panitumumab with FOLFOX4 versus FOLFOX4 alone as first-line treatment for metastatic colorectal cancer (mCRC): results from the randomised phase III PRIME study
(2010)
Files
No attached file found for this publication.
Details
- Authors
- Affiliations
Citations
Siena, S., Douillard, J.-Y., Tabernero, J., Cassidy, J., Burkes, R., Barugel, M. E., Humblet, Y., Cunningham, D., Wolf, M., & Gansert, J. (2010). Panitumumab with FOLFOX4 versus FOLFOX4 alone as first-line treatment for metastatic colorectal cancer (mCRC): results from the randomised phase III PRIME study. Onkologie : international journal for cancer research and treatment, 33, 68-69. (Original work published 2010)